- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NIPERs focuses on research, 3D products to fight COVID19
NIPER-Raebareli has also initiated a mega project with IIT and an industrial partner in the development of new immuno-booster formulation utilizing traditionally used shrubs. NIPER Kolkata is working on an indigenous cost-effective ICU VENTILATOR in collaboration with CSIR CECRI and a private manufacturer.
New Delhi: A large number of multi-faceted research proposals have been submitted by various National Institutes of Pharmaceutical Education and Research (NIPERs), towards the containment, identification, and treatment of COVID-19 to relevant agencies for approval.
The key themes of these proposals include the design of protease targeting COVID-19 antiviral agents (NIPER-Mohali), computationally guided drug-repurposing using the FDA approved drug-database (NIPER-Mohali and Raebareli), analysis of pro-drug to drug conversion of Remdesvir (NIPER, Mohali), adjuvant-therapy based nasal spray for ailing patients (NIPER-Hyderabad), quantum-dot based and conductivity based biosensor development for rapid COVID-19 (NIPER-Ahmedabad) testing, and an interesting study about the control of strokes incidence during Covid-19.
NIPER-Raebareli has also initiated a mega project with IIT and an industrial partner in the development of new immuno-booster formulation utilizing traditionally used shrubs. NIPER Kolkata is working on an indigenous cost-effective ICU VENTILATOR in collaboration with CSIR CECRI and a private manufacturer.
National Institutes of Pharmaceutical Education and Research (NIPERs) are the institutes of national importance under the aegis of the Department of Pharmaceutical, Ministry of Chemicals and Fertilizers. The seven institutes are functional at Ahmadabad, Hyderabad, Hajipur, Kolkata, Guwahati, Mohali, and Raebareli.
A meeting of all the Directors and Chairmen of the institutions through video conferencing was held under the chairmanship of Dr P D Vaghela, Secretary, Pharmaceuticals here to review their performance in research & innovation activities especially with regard to the ways in which NIPERs have and can contribute in country's fight against COVID-19 pandemic.
Director, NIPER Guwahati informed about the fabrication of prototypes for 3D printed face-shields, a "hands-free object" for the touch-less opening of doors, drawers & elevators, antiviral masks as well as skin-friendly herbal sanitizers. He informed that industrial-scale manufacturing of these products is being done in collaboration with Hindustan Antibiotics Limited, a departmental PSU. At NIPER Mohali, in association with the Government of Punjab, steps have been initiated to set-up an RT-PCR based COVID-19 testing facility to expedite COVID-19 confirmatory tests in the state.
Dr Vaghela mentioned that all COVID-19 related research and product development initiatives should be done briskly to provide help to the needy at the earliest.
In particular, he stressed that all licensing and commercialization aspects of the developed solutions at NIPERs should be coordinated through regulatory agencies on priority so that the products reach the market in this hour of need. Through these research efforts and societal participation in helping the people, NIPERs are committed to work in solidarity with different groups and serve the country in the best possible way.
Read also: Cipla becomes 2nd firm to enter tie-up with Gilead to make remdesivir in India
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751